Last 12 months
Inside the activity.
8 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 4 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 3 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 01, 2020 Filed Feb 4, 2020 22:26 UTC |
Weber Kathleen GallagherEVP & BU Lead - Molecular
|
GrantCommon Stock | 10,238 | $7.17 | $73,355.27 |
DisclosureSEC source: 0001593968-20-000318 · primary_01.xml · nonDerivative · entry 7 Weber Kathleen Gallagher · CIK 0001756089 · EVP & BU Lead - Molecular 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,444 F3 · kind: Shares delivered in settlement of vested performance units that did not constitute a derivative security. Read SEC document |
| February 01, 2020 Filed Feb 4, 2020 22:26 UTC |
Weber Kathleen GallagherEVP & BU Lead - Molecular
|
Tax withholdingCommon Stock | 3,023 | $7.17 | $21,659.80 |
DisclosureSEC source: 0001593968-20-000318 · primary_01.xml · nonDerivative · entry 6 Weber Kathleen Gallagher · CIK 0001756089 · EVP & BU Lead - Molecular 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,206 F4 · kind: Withholding of shares to pay tax liability associated with the vesting of performance units Read SEC document |
| February 01, 2020 Filed Feb 4, 2020 22:26 UTC |
Weber Kathleen GallagherEVP & BU Lead - Molecular
|
GrantCommon Stock | 10,238 | $7.17 | $73,355.27 |
DisclosureSEC source: 0001593968-20-000318 · primary_01.xml · nonDerivative · entry 5 Weber Kathleen Gallagher · CIK 0001756089 · EVP & BU Lead - Molecular 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,229 F3 · kind: Shares delivered in settlement of vested performance units that did not constitute a derivative security. Read SEC document |
| February 01, 2020 Filed Feb 4, 2020 22:26 UTC |
Weber Kathleen GallagherEVP & BU Lead - Molecular
|
GrantCommon Stock | 32,516 | $7.17 | $232,977.14 |
DisclosureSEC source: 0001593968-20-000318 · primary_01.xml · nonDerivative · entry 4 Weber Kathleen Gallagher · CIK 0001756089 · EVP & BU Lead - Molecular 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,991 F2 · kind: Restricted stock award with 3 year vesting schedule Read SEC document |
| February 01, 2020 Filed Feb 4, 2020 22:26 UTC |
Weber Kathleen GallagherEVP & BU Lead - Molecular
|
Tax withholdingCommon Stock | 1,467 | $7.17 | $10,511.06 |
DisclosureSEC source: 0001593968-20-000318 · primary_01.xml · nonDerivative · entry 3 Weber Kathleen Gallagher · CIK 0001756089 · EVP & BU Lead - Molecular 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,475 F1 · kind: Withholding of shares to pay the tax liability associated with vesting of restricted shares Read SEC document |
| February 01, 2020 Filed Feb 4, 2020 22:26 UTC |
Weber Kathleen GallagherEVP & BU Lead - Molecular
|
Tax withholdingCommon Stock | 901 | $7.17 | $6,455.67 |
DisclosureSEC source: 0001593968-20-000318 · primary_01.xml · nonDerivative · entry 2 Weber Kathleen Gallagher · CIK 0001756089 · EVP & BU Lead - Molecular 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,942 F1 · kind: Withholding of shares to pay the tax liability associated with vesting of restricted shares Read SEC document |
| February 01, 2020 Filed Feb 4, 2020 22:26 UTC |
Weber Kathleen GallagherEVP & BU Lead - Molecular
|
Tax withholdingCommon Stock | 1,536 | $7.17 | $11,005.44 |
DisclosureSEC source: 0001593968-20-000318 · primary_01.xml · nonDerivative · entry 1 Weber Kathleen Gallagher · CIK 0001756089 · EVP & BU Lead - Molecular 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,843 F1 · kind: Withholding of shares to pay the tax liability associated with vesting of restricted shares Read SEC document |
| February 01, 2020 Filed Feb 4, 2020 22:25 UTC |
Zezzo II AnthonyEVP & BU Lead - Infectious
|
Tax withholdingCommon Stock | 7,531 | $7.17 | $53,959.62 |
DisclosureSEC source: 0001593968-20-000317 · primary_01.xml · nonDerivative · entry 8 Zezzo II Anthony · CIK 0001509328 · EVP & BU Lead - Infectious 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 227,867 F4 · kind: Withholding of shares to pay tax liability associated with the vesting of performance units Read SEC document |
| February 01, 2020 Filed Feb 4, 2020 22:25 UTC |
Zezzo II AnthonyEVP & BU Lead - Infectious
|
GrantCommon Stock | 16,560 | $7.17 | $118,652.40 |
DisclosureSEC source: 0001593968-20-000317 · primary_01.xml · nonDerivative · entry 7 Zezzo II Anthony · CIK 0001509328 · EVP & BU Lead - Infectious 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,398 F3 · kind: Shares delivered in settlement of vested performance units that did not constitute a derivative security. Read SEC document |
| February 01, 2020 Filed Feb 4, 2020 22:25 UTC |
Zezzo II AnthonyEVP & BU Lead - Infectious
|
Tax withholdingCommon Stock | 7,475 | $7.17 | $53,558.38 |
DisclosureSEC source: 0001593968-20-000317 · primary_01.xml · nonDerivative · entry 6 Zezzo II Anthony · CIK 0001509328 · EVP & BU Lead - Infectious 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 218,838 F4 · kind: Withholding of shares to pay tax liability associated with the vesting of performance units Read SEC document |
| February 01, 2020 Filed Feb 4, 2020 22:25 UTC |
Zezzo II AnthonyEVP & BU Lead - Infectious
|
GrantCommon Stock | 16,560 | $7.17 | $118,652.40 |
DisclosureSEC source: 0001593968-20-000317 · primary_01.xml · nonDerivative · entry 5 Zezzo II Anthony · CIK 0001509328 · EVP & BU Lead - Infectious 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 226,313 F3 · kind: Shares delivered in settlement of vested performance units that did not constitute a derivative security. Read SEC document |
| February 01, 2020 Filed Feb 4, 2020 22:25 UTC |
Zezzo II AnthonyEVP & BU Lead - Infectious
|
GrantCommon Stock | 34,698 | $7.17 | $248,611.17 |
DisclosureSEC source: 0001593968-20-000317 · primary_01.xml · nonDerivative · entry 4 Zezzo II Anthony · CIK 0001509328 · EVP & BU Lead - Infectious 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209,753 F2 · kind: Restricted stock award with 3 year vesting schedule Read SEC document |
| February 01, 2020 Filed Feb 4, 2020 22:25 UTC |
Zezzo II AnthonyEVP & BU Lead - Infectious
|
Tax withholdingCommon Stock | 3,175 | $7.17 | $22,748.88 |
DisclosureSEC source: 0001593968-20-000317 · primary_01.xml · nonDerivative · entry 3 Zezzo II Anthony · CIK 0001509328 · EVP & BU Lead - Infectious 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,055 F1 · kind: Withholding of shares to pay the tax liability associated with vesting of restricted shares Read SEC document |
| February 01, 2020 Filed Feb 4, 2020 22:25 UTC |
Zezzo II AnthonyEVP & BU Lead - Infectious
|
Tax withholdingCommon Stock | 1,644 | $7.17 | $11,779.26 |
DisclosureSEC source: 0001593968-20-000317 · primary_01.xml · nonDerivative · entry 2 Zezzo II Anthony · CIK 0001509328 · EVP & BU Lead - Infectious 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,230 F1 · kind: Withholding of shares to pay the tax liability associated with vesting of restricted shares Read SEC document |
| February 01, 2020 Filed Feb 4, 2020 22:25 UTC |
Zezzo II AnthonyEVP & BU Lead - Infectious
|
Tax withholdingCommon Stock | 3,736 | $7.17 | $26,768.44 |
DisclosureSEC source: 0001593968-20-000317 · primary_01.xml · nonDerivative · entry 1 Zezzo II Anthony · CIK 0001509328 · EVP & BU Lead - Infectious 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 179,874 F1 · kind: Withholding of shares to pay the tax liability associated with vesting of restricted shares Read SEC document |
| February 01, 2020 Filed Feb 4, 2020 22:24 UTC |
Anthony Michele MarieVP, Finance and Controller
|
GrantOption (right to buy) · Derivative | 29,071 | $7.17 Strike: $7.17 | $208,293.72 |
DisclosureSEC source: 0001593968-20-000316 · primary_01.xml · derivative · entry 5 Miller Michele Marie · CIK 0001756098 · VP, Finance and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,662 Underlying: OraSure Technologies, Inc. · 29,071 shares Expires 2030-02-01 F3 · kind: Nonqualified stock options, vesting and exercisable over a four year period, with one-fourth of the options vesting on the first anniversary date of the grant and the remainder vesting ratably on a monthly basis, over the remaining 36 months. Read SEC document |
| February 01, 2020 Filed Feb 4, 2020 22:24 UTC |
Anthony Michele MarieVP, Finance and Controller
|
GrantCommon Stock | 7,545 | $7.17 | $54,059.93 |
DisclosureSEC source: 0001593968-20-000316 · primary_01.xml · nonDerivative · entry 4 Miller Michele Marie · CIK 0001756098 · VP, Finance and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,861 F2 · kind: Restricted stock award with 3 year vesting schedule Read SEC document |
| February 01, 2020 Filed Feb 4, 2020 22:24 UTC |
Anthony Michele MarieVP, Finance and Controller
|
Tax withholdingCommon Stock | 429 | $7.17 | $3,073.79 |
DisclosureSEC source: 0001593968-20-000316 · primary_01.xml · nonDerivative · entry 3 Miller Michele Marie · CIK 0001756098 · VP, Finance and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,316 F1 · kind: Withholding of shares to pay the tax liability associated with vesting of restricted shares Read SEC document |
| February 01, 2020 Filed Feb 4, 2020 22:24 UTC |
Anthony Michele MarieVP, Finance and Controller
|
Tax withholdingCommon Stock | 109 | $7.17 | $780.99 |
DisclosureSEC source: 0001593968-20-000316 · primary_01.xml · nonDerivative · entry 2 Miller Michele Marie · CIK 0001756098 · VP, Finance and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,745 F1 · kind: Withholding of shares to pay the tax liability associated with vesting of restricted shares Read SEC document |
| February 01, 2020 Filed Feb 4, 2020 22:24 UTC |
Anthony Michele MarieVP, Finance and Controller
|
Tax withholdingCommon Stock | 217 | $7.17 | $1,554.81 |
DisclosureSEC source: 0001593968-20-000316 · primary_01.xml · nonDerivative · entry 1 Miller Michele Marie · CIK 0001756098 · VP, Finance and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,854 F1 · kind: Withholding of shares to pay the tax liability associated with vesting of restricted shares Read SEC document |
| February 01, 2020 Filed Feb 4, 2020 22:23 UTC |
Cuca RobertoCFO
|
GrantCommon Stock | 47,908 | $7.17 | $343,260.82 |
DisclosureSEC source: 0001593968-20-000315 · primary_01.xml · nonDerivative · entry 2 Cuca Roberto · CIK 0001591474 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,712 F2 · kind: Restricted stock award with 3 year vesting schedule Read SEC document |
| February 01, 2020 Filed Feb 4, 2020 22:23 UTC |
Cuca RobertoCFO
|
Tax withholdingCommon Stock | 2,771 | $7.17 | $19,854.22 |
DisclosureSEC source: 0001593968-20-000315 · primary_01.xml · nonDerivative · entry 1 Cuca Roberto · CIK 0001591474 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,804 F1 · kind: Withholding of shares to pay the tax liability associated with vesting of restricted shares Read SEC document |
| February 01, 2020 Filed Feb 4, 2020 22:21 UTC |
TANG STEPHEN S PHDPresident and CEO
|
GrantCommon Stock | 84,997 | $7.17 | $609,003.51 |
DisclosureSEC source: 0001593968-20-000313 · primary_01.xml · nonDerivative · entry 2 TANG STEPHEN S PHD · CIK 0001240718 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,763 F2 · kind: Restricted stock award with 3 year vesting schedule Read SEC document |
| February 01, 2020 Filed Feb 4, 2020 22:21 UTC |
TANG STEPHEN S PHDPresident and CEO
|
Tax withholdingCommon Stock | 5,194 | $7.17 | $37,215.01 |
DisclosureSEC source: 0001593968-20-000313 · primary_01.xml · nonDerivative · entry 1 TANG STEPHEN S PHD · CIK 0001240718 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,766 F1 · kind: Withholding of shares to pay the tax liability associated with vesting of restricted shares Read SEC document |
| August 12, 2019 Filed Aug 14, 2019 20:20 UTC |
Datin James ADirector
|
GrantCommon Stock | 13,432 | $7.45 | $100,001.24 |
DisclosureSEC source: 0001593968-19-001731 · primary_01.xml · nonDerivative · entry 1 Datin James A · CIK 0001337791 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,432 F1 · kind: Grant of restricted shares under the OraSure Technologies, Inc. Stock Award Plan, cliff vesting on August 12, 2021. Vesting shall cease immediately if the named individual voluntarily ceases to serve as a member of the Board of Directors. Read SEC document |
| May 21, 2019 Filed May 22, 2019 20:33 UTC |
SARIN ARADHANADirector
|
GrantCommon Stock | 12,382 | $8.48 | $104,999.36 |
DisclosureSEC source: 0001593968-19-001162 · primary_01.xml · nonDerivative · entry 1 SARIN ARADHANA · CIK 0001729110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,865 F1 · kind: Grant of restricted shares under the OraSure Technologies, Inc. Stock Award Plan, cliff vesting on May 15, 2020. Vesting shall cease immediately if the named individual voluntarily ceases to serve as a member of the Board of Directors. Read SEC document |
| May 21, 2019 Filed May 22, 2019 20:12 UTC |
HOBBS EAMONN PDirector
|
GrantCommon Stock | 12,382 | $8.48 | $104,999.36 |
DisclosureSEC source: 0001593968-19-001156 · primary_01.xml · nonDerivative · entry 1 HOBBS EAMONN P · CIK 0001235670 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,502 F1 · kind: Grant of restricted shares under the OraSure Technologies, Inc. Stock Award Plan, cliff vesting on May 15, 2020. Vesting shall cease immediately if the named individual voluntarily ceases to serve as a member of the Board of Directors. Read SEC document |
| May 21, 2019 Filed May 22, 2019 21:06 UTC |
Celano MichaelDirector
|
GrantCommon Stock | 15,330 | $8.48 | $129,998.40 |
DisclosureSEC source: 0001593968-19-001167 · primary_01.xml · nonDerivative · entry 1 Celano Michael · CIK 0001377582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,642 F1 · kind: Grant of restricted shares under the OraSure Technologies, Inc. Stock Award Plan, cliff vesting on May 15, 2020. Vesting shall cease immediately if the named individual voluntarily ceases to serve as a member of the Board of Directors. Read SEC document |
| May 21, 2019 Filed May 22, 2019 20:38 UTC |
Patrick Charles WDirector
|
GrantCommon Stock | 12,382 | $8.48 | $104,999.36 |
DisclosureSEC source: 0001593968-19-001165 · primary_01.xml · nonDerivative · entry 1 Patrick Charles W · CIK 0001348789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,436 F1 · kind: Grant of restricted shares under the OraSure Technologies, Inc. Stock Award Plan, cliff vesting on May 15, 2020. Vesting shall cease immediately if the named individual voluntarily ceases to serve as a member of the Board of Directors. Read SEC document |
| May 21, 2019 Filed May 22, 2019 20:36 UTC |
LANCASTER RONNY BDirector
|
GrantCommon Stock | 12,382 | $8.48 | $104,999.36 |
DisclosureSEC source: 0001593968-19-001163 · primary_01.xml · nonDerivative · entry 1 LANCASTER RONNY B · CIK 0001238960 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,029 F1 · kind: Grant of restricted shares under the OraSure Technologies, Inc. Stock Award Plan, cliff vesting on May 15, 2020. Vesting shall cease immediately if the named individual voluntarily ceases to serve as a member of the Board of Directors. Read SEC document |
| May 21, 2019 Filed May 22, 2019 20:37 UTC |
Aspinall Mara G.Director
|
GrantCommon Stock | 12,382 | $8.48 | $104,999.36 |
DisclosureSEC source: 0001593968-19-001164 · primary_01.xml · nonDerivative · entry 1 Aspinall Mara G. · CIK 0001623049 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,526 F1 · kind: Grant of restricted shares under the OraSure Technologies, Inc. Stock Award Plan, cliff vesting on May 15, 2020. Vesting shall cease immediately if the named individual voluntarily ceases to serve as a member of the Board of Directors. Read SEC document |
| May 14, 2019 Filed May 14, 2019 20:44 UTC |
TANG STEPHEN S PHDPresident and CEO
|
PurchaseCommon Stock | 1,000 | $8.56 | $8,560.00 |
DisclosureSEC source: 0001593968-19-001098 · primary_01.xml · nonDerivative · entry 1 TANG STEPHEN S PHD · CIK 0001240718 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,960 Read SEC document |
| May 13, 2019 Filed May 14, 2019 20:41 UTC |
JERRETT JACK ESVP & General Counsel
|
PurchaseCommon Stock | 8,687 | $8.55 | $74,273.85 |
DisclosureSEC source: 0001593968-19-001097 · primary_01.xml · nonDerivative · entry 2 JERRETT JACK E · CIK 0001209785 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,885 Read SEC document |
| May 13, 2019 Filed May 14, 2019 20:41 UTC |
JERRETT JACK ESVP & General Counsel
|
PurchaseCommon Stock | 1,313 | $8.54 | $11,213.02 |
DisclosureSEC source: 0001593968-19-001097 · primary_01.xml · nonDerivative · entry 1 JERRETT JACK E · CIK 0001209785 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,198 Read SEC document |
| May 10, 2019 Filed May 14, 2019 20:38 UTC |
Cuca RobertoCFO
|
PurchaseCommon Stock | 407 | $9.00 | $3,663.00 |
DisclosureSEC source: 0001593968-19-001096 · primary_01.xml · nonDerivative · entry 5 Cuca Roberto · CIK 0001591474 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,575 Read SEC document |
| May 10, 2019 Filed May 14, 2019 20:38 UTC |
Cuca RobertoCFO
|
PurchaseCommon Stock | 700 | $9.03 | $6,321.00 |
DisclosureSEC source: 0001593968-19-001096 · primary_01.xml · nonDerivative · entry 4 Cuca Roberto · CIK 0001591474 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,168 Read SEC document |
| May 10, 2019 Filed May 14, 2019 20:38 UTC |
Cuca RobertoCFO
|
PurchaseCommon Stock | 1,200 | $9.02 | $10,824.00 |
DisclosureSEC source: 0001593968-19-001096 · primary_01.xml · nonDerivative · entry 3 Cuca Roberto · CIK 0001591474 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,468 Read SEC document |
| May 10, 2019 Filed May 14, 2019 20:38 UTC |
Cuca RobertoCFO
|
PurchaseCommon Stock | 1,300 | $9.01 | $11,713.00 |
DisclosureSEC source: 0001593968-19-001096 · primary_01.xml · nonDerivative · entry 2 Cuca Roberto · CIK 0001591474 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,268 Read SEC document |
| May 10, 2019 Filed May 14, 2019 20:38 UTC |
Cuca RobertoCFO
|
PurchaseCommon Stock | 6,393 | $9.04 | $57,792.72 |
DisclosureSEC source: 0001593968-19-001096 · primary_01.xml · nonDerivative · entry 1 Cuca Roberto · CIK 0001591474 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,968 Read SEC document |
| May 07, 2019 Filed May 8, 2019 20:27 UTC |
Cuca RobertoCFO
|
Tax withholdingCommon Stock | 1,359 | $9.84 | $13,372.56 |
DisclosureSEC source: 0001593968-19-001062 · primary_01.xml · nonDerivative · entry 1 Cuca Roberto · CIK 0001591474 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,575 F1 · kind: Withholding of shares to pay the tax liability associated with vesting of restricted shares Read SEC document |
| May 06, 2019 Filed May 7, 2019 20:20 UTC |
Patrick Charles WDirector
|
Tax withholdingCommon Stock | 1,980 | $9.88 | $19,567.35 |
DisclosureSEC source: 0001593968-19-001056 · primary_01.xml · nonDerivative · entry 1 Patrick Charles W · CIK 0001348789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,054 F1 · kind: Withholding of shares to pay the tax liability associated with vesting of restricted shares Read SEC document |
| May 06, 2019 Filed May 7, 2019 20:19 UTC |
SARIN ARADHANADirector
|
Tax withholdingCommon Stock | 1,661 | $9.88 | $16,414.83 |
DisclosureSEC source: 0001593968-19-001055 · primary_01.xml · nonDerivative · entry 1 SARIN ARADHANA · CIK 0001729110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,483 F1 · kind: Withholding of shares to pay the tax liability associated with vesting of restricted shares Read SEC document |
| May 06, 2019 Filed May 7, 2019 20:18 UTC |
HOBBS EAMONN PDirector
|
Tax withholdingCommon Stock | 1,351 | $9.88 | $13,351.26 |
DisclosureSEC source: 0001593968-19-001054 · primary_01.xml · nonDerivative · entry 1 HOBBS EAMONN P · CIK 0001235670 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,120 F1 · kind: Withholding of shares to pay the tax liability associated with vesting of restricted shares Read SEC document |
| May 06, 2019 Filed May 7, 2019 20:15 UTC |
LANCASTER RONNY BDirector
|
Tax withholdingCommon Stock | 1,873 | $9.88 | $18,509.92 |
DisclosureSEC source: 0001593968-19-001053 · primary_01.xml · nonDerivative · entry 1 LANCASTER RONNY B · CIK 0001238960 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,647 F1 · kind: Withholding of shares to pay the tax liability associated with vesting of restricted shares Read SEC document |
| April 18, 2019 Filed Apr 22, 2019 20:31 UTC |
REED MICHAELSVP R&D and CSO
|
Tax withholdingCommon Stock | 2,674 | $9.55 | $25,536.70 |
DisclosureSEC source: 0001593968-19-000974 · primary_01.xml · nonDerivative · entry 1 REED MICHAEL · CIK 0001672641 · SVP R&D and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,217 F1 · kind: Withholding of shares to pay the tax liability associated with vesting of restricted shares Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 20:29 UTC |
TANG STEPHEN S PHDPresident and CEO
|
Exercise / conversionOption (right to buy) · Derivative | 16,667 | $0.00 Strike: $8.33 | $0.00 |
DisclosureSEC source: 0001593968-19-000917 · primary_01.xml · derivative · entry 3 TANG STEPHEN S PHD · CIK 0001240718 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: OraSure Technologies, Inc. · 16,667 shares Expires 2026-11-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Non-qualified stock options granted on November 14, 2016, vesting and exercisable on a monthly basis over the 24 months immediately following the grant date. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 20:29 UTC |
TANG STEPHEN S PHDPresident and CEO
|
SaleCommon Stock | 16,667 | $11.10 | $185,015.37 |
DisclosureSEC source: 0001593968-19-000917 · primary_01.xml · nonDerivative · entry 2 TANG STEPHEN S PHD · CIK 0001240718 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,960 Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 20:29 UTC |
TANG STEPHEN S PHDPresident and CEO
|
Exercise / conversionCommon Stock | 16,667 | $8.33 | $138,752.78 |
DisclosureSEC source: 0001593968-19-000917 · primary_01.xml · nonDerivative · entry 1 TANG STEPHEN S PHD · CIK 0001240718 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,627 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 21:43 UTC |
Anthony Michele MarieVP, Finance and Controller
|
GrantOption (right to buy) · Derivative | 13,986 | $0.00 Strike: $12.98 | $0.00 |
DisclosureSEC source: 0001593968-19-000348 · primary_01.xml · derivative · entry 5 Miller Michele Marie · CIK 0001756098 · VP, Finance and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,591 Underlying: OraSure Technologies, Inc. · 13,986 shares Expires 2029-02-01 F3 · kind: Nonqualified stock options, vesting and exercisable over a four year period, with one-fourth of the options vesting on the first anniversary date of the grant and the remainder vesting ratably on a monthly basis, over the remaining 36 months. Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 21:43 UTC |
Anthony Michele MarieVP, Finance and Controller
|
GrantCommon Stock | 3,813 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-19-000348 · primary_01.xml · nonDerivative · entry 4 Miller Michele Marie · CIK 0001756098 · VP, Finance and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,071 F2 · kind: Restricted stock award with 3 year vesting schedule Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.